Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: A systematic review

European Respiratory Journal

Volumn 31, Issue 3, 2008, Pages 625-632

  Athanassa, Z ^a   Siempos, I I ^a   Falagas, M E ^a,b,c  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial resistance; Critical illness; Healthcare associated pneumonia; Morbidity; Nosocomial pneumonia; Survival

Indexed keywords

DISEASE SEVERITY; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW; VENTILATOR ASSOCIATED PNEUMONIA; ARTIFICIAL VENTILATION; DRUG EFFECT; PATHOGENICITY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS INFECTION; STATISTICS;

HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; METHICILLIN RESISTANCE; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 41949141533     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00081007     Document Type: Review

References (31)

1. Barlow G, Nathwani D. Is antibiotic resistance a problem? A practical guide for hospital clinicians. Postgrad Med J 2005; 81: 680-692.
2. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59.
3. Travers K, Barza M. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis 2002; 34: Suppl. 3, S131-S134.
4. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28: 273-279.
5. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003; 37: 1453-1460.
6. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122: 262-268.
7. Harbarth S, Nobre V, Pittet D. Does antibiotic selection impact patient outcome? Clin Infect Dis 2007; 44: 87-93.
8. Schmitz FJ, Mac-Kenzie CR, Geisel R, et al. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Eur J Epidemiol 1997; 13: 699-708.
9. Hershow RC, Khayr WF, Smith NL. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol 1992; 13: 587-593.
10. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator- associated pneumonia. Chest 2006; 130: 597-604.
11. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903.
12. Fridkin SK, Hill HA, Volkova NV, et al. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002; 8: 697-701.
13. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007; 35: 146-154.
14. Combes A, Luyt CE, Fagon JY, et al. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 2004; 170: 786-792.
15. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 versus 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290: 2588-2598.
16. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29: 1171-1177.
17. Theaker C, Ormond-Walshe S, Azadian B, Soni N. MRSA in the critically ill. J Hosp Infect 2001; 48: 98-102.
18. Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 2006; 10: R97.
19. Zahar JR, Clec'h C, Tafflet M, et al. Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? Clin Infect Dis 2005; 41: 1224-1231.
20. De Ryke CA, Lodise TP, Rybak MJ, McKinnon PS. Epidemiology, treatment and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 2005; 128: 1414-1422.
21. Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Ruden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German nosocomial infection surveillance system (KISS). Infection 2005; 33: 50-55.
22. Pujol M, Corbella X, Pena C, et al. Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis 1998; 17: 622-628.
23. Rello J, Torres A, Valles RJ, Gonzalez VJ, Artigas A, Rodriguez-Roisin R. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150: 1545-1549.
24. Ibelings MMS, Bruining HA. Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 1998; 164: 411-418.
25. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalea M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29: 1171-1177.
26. Lentino JR, Hennein H, Krause S, et al. A comparison of pneumonia caused by gentamicin, methicillin-resistant and gentamicin, methicillin- sensitive Staphylococcus aureus: epidemiologic and clinical studies. Infect control 1985; 6: 267-272.
27. Stryjewski ME, Szczech LA, Benjamin DK Jr, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44: 190-196.
28. Kopp BJ, Nix DE, Armstrong EP. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 2004; 38: 1377-1382.
29. Chang FY, Peacock JE Jr, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003; 82: 333-339.
30. Soriano A, Martines JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30: 368-373.
31. Harbarth S, Rutshmann O, Sudre P, Pitted D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158: 182-189.